These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31105996)

  • 1. The human positive cofactor 4 promotes androgen-independent prostate cancer development and progression through HIF-1α/β-catenin pathway.
    Luo P; Jiang Q; Fang Q; Wang Y; Wang Z; Yang J; Tan X; Li W; Shi C
    Am J Cancer Res; 2019; 9(4):682-698. PubMed ID: 31105996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect.
    Luo P; Zhang C; Liao F; Chen L; Liu Z; Long L; Jiang Z; Wang Y; Wang Z; Liu Z; Miao H; Shi C
    Cell Commun Signal; 2019 Apr; 17(1):36. PubMed ID: 30992017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway.
    Su X; Yang Y; Ma L; Luo P; Shen K; Dai H; Jiang Y; Shuai L; Liu Z; You J; Min K; Shi C; Chen Z
    Onco Targets Ther; 2020; 13():12213-12223. PubMed ID: 33273827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal LINC01213 Plays a Role in the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manners.
    Guo Z; Lu X; Yang F; He C; Qin L; Yang N; Han C; Wu J
    J Oncol; 2022; 2022():8058770. PubMed ID: 35310913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
    Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
    Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Actinin-4 Promotes the Progression of Prostate Cancer Through the Akt/GSK-3β/β-Catenin Signaling Pathway.
    Park S; Kang M; Kim S; An HT; Gettemans J; Ko J
    Front Cell Dev Biol; 2020; 8():588544. PubMed ID: 33363146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer.
    Chau CH; Permenter MG; Steinberg SM; Retter AS; Dahut WL; Price DK; Figg WD
    Cancer Biol Ther; 2005 Nov; 4(11):1222-5. PubMed ID: 16205110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression.
    Kim JH; Lee H; Shin EA; Kim DH; Choi JB; Kim SH
    Expert Opin Ther Targets; 2017 Sep; 21(9):911-920. PubMed ID: 28816549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deprivation therapy has no effect on Pim-1 expression in a mouse model of prostate cancer.
    Wang J; Li G; Li B; Song H; Shang Z; Jiang N; Niu Y
    Oncol Lett; 2017 Jun; 13(6):4364-4370. PubMed ID: 28599438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer small extracellular vesicles participate in androgen-independent transformation of prostate cancer by transferring let-7a-5p.
    Lei L; Yu L; Fan W; Hao X
    Heliyon; 2022 Dec; 8(12):e12114. PubMed ID: 36578414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial.
    Shazer RL; Jain A; Galkin AV; Cinman N; Nguyen KN; Natale RB; Gross M; Green L; Bender LI; Holden S; Kaplan L; Agus DB
    BJU Int; 2006 Apr; 97(4):691-7. PubMed ID: 16536755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene microarray assessment of multiple genes and signal pathways involved in androgen-dependent prostate cancer becoming androgen independent.
    Liu JB; Dai CM; Su XY; Cao L; Qin R; Kong QB
    Asian Pac J Cancer Prev; 2014; 15(22):9791-5. PubMed ID: 25520106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of androgen-dependent and -independent activation of signal transduction pathways for cell proliferation of prostate cancer cells.
    Inoue T; Kobayashi T; Terada N; Shimizu Y; Kamoto T; Ogawa O; Nakamura E
    Expert Rev Endocrinol Metab; 2007 Sep; 2(5):689-704. PubMed ID: 30736131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].
    Gan L; Yin ZF; Li M
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):419-21. PubMed ID: 18581899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
    BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of membrane antigen differentially expressed in androgen-dependent prostate cancer and androgen-independent prostate cancer].
    Zhang X; Tang Z; Qi L; Chen H; Luo Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):817-23. PubMed ID: 22954909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of
    Zhou W; Shi K; Ji L; Wu R; Chen Y; Tu H; Zhou B; Wang Z; Zhang M
    J Cancer; 2018; 9(19):3620-3625. PubMed ID: 30310520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
    Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
    Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.